Apheresis treatment in Lambert-Eaton myasthenic syndrome

Therapeutic Apheresis

Volumn 4, Issue 4, 2000, Pages 287-290

  Motomura, Masakatsu ^a   Hamasaki, Shinji ^a   Nakane, Shunya ^a   Fukuda, Taku ^a   Nakao, Yoko K ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nagasaki Kita Hospital   (Japan)

Author keywords

Autoantibody; Double filtration plasmapheresis; Lambert Eaton myasthenic syndrome; P Q type VGCC; Plasma exchange

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

ACETYLCHOLINE RELEASE; AGED; ANTIBODY PRODUCTION; APHERESIS; ARTICLE; CASE REPORT; CHOLINERGIC TRANSMISSION; EATON LAMBERT SYNDROME; ELECTROMYOGRAM; FEMALE; HUMAN; MALE; MUSCLE WEAKNESS; PLASMAPHERESIS; PRIORITY JOURNAL;

AGED; ALGORITHMS; AUTOANTIBODIES; CALCIUM CHANNELS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; PLASMA EXCHANGE; PLASMAPHERESIS;

EID: 0033851473     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2000.004004287.x     Document Type: Article

References (32)

1. Bronchial neoplasm with myasthenia: Prolonged apnea after administration of succinylcholine
2. Defect of neuromuscular conduction associated with malignant neoplasm
3. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma
4. Autoimmune etiology for myasthenic (Eaton-Lambert) syndrome
5. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse
6. The Lambert-Eaton myasthenic syndrome. A review of 50 cases
7. Calcium spike electrogenesis and other electrical activity in continuously cultured small cell lung carcinoma of the lung
8. Antibodies to motor nerve terminals: An electrophysiological study of a human myasthenic syndrome transferred to mouse
9. Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG
10. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones
11. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome
12. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line
13. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omegaconotoxin and adenosine
14. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient
15. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells
16. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome
17. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes
18. Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome
19. Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome
20. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
21. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
22. Calcium channel blockers and transmitter release at the normal human neuromuscular junction
23. The effect of high-dose intravenous gammaglobulin in Lambert-Eaton myasthenic syndrome
24. Alteration of the titer of autoantibody to voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome after the plasmapheresis and immunosuppressive therapy
25. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome
26. A treatment algorithm for Lambert-Eaton myasthenic syndrome
27. Treatment of Lambert-Eaton syndrome: 3,4 diaminopyridine and pyridostigmine
28. 3,4-diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome
29. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma
30. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome
31. Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure
32. Acute ventilatory failure in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine